Trevena

+$0.09 (+4.41%) Today
+$0.02 (+0.94%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Trevena and other stocks, options, and ETFs commission-free!

About TRVN

Trevena, Inc. engages in the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its product candidates include Oliceridine injection, TRV250, TRV734, and TRV045.

CEO
Carrie L. Bourdow
Employees
25
Headquarters
Chesterbrook, Pennsylvania
Founded
2007

TRVN Key Statistics

Market Cap
343.51M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.87M
High Today
$2.15
Low Today
$2.01
Open Price
$2.06
Volume
2.35M
52 Week High
$3.68
52 Week Low
$1.24

TRVN Earnings

-$0.09
-$0.06
-$0.03
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure